TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH PRODUCTOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL POLYMER BIOMATERIALS MARKET, BY PRODUCT
6.1. Overview
6.2. Polylactic Acid (PLA)
6.3. Polyglycolic Acid (PGA)
6.4. Polyurethanes
6.5. Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
6.6. Polyetheretherketone (PEEK)
6.7. Polydioxanone (PDO)
6.8. Others
7. GLOBAL POLYMER BIOMATERIALS MARKET, BY APPLICATION
7.1. Overview
7.2. Cardiovascular
7.3. Dental
7.4. Orthopedic
7.5. Plastic Surgery
7.6. Neurology
7.7. Others
8. GLOBAL POLYMER BIOMATERIALS MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Polymer Biomaterials Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Polymer Biomaterials Market,
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2023
9.8.2. Major Players R&D Expenditure. 2023
10. COMPANY PROFILES
10.1. Stryker
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. BASF SE
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Evonik Industries AG
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. DSM
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Bezwada Biomedical, LLC
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Corbion
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Victrex plc (Invibio Ltd.)
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. INTERNATIONAL POLYMER ENGINEERING
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. COVALON TECHNOLOGIES LTD.
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Medtronic
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. Abbott
10.11.1. Company Overview
10.11.2. Financial Overview
10.11.3. Products Offered
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
10.12. Elixir Medical
10.12.1. Company Overview
10.12.2. Financial Overview
10.12.3. Products Offered
10.12.4. Key Developments
10.12.5. SWOT Analysis
10.12.6. Key Strategies
10.13. REVA Medical, LLC
10.13.1. Company Overview
10.13.2. Financial Overview
10.13.3. Products Offered
10.13.4. Key Developments
10.13.5. SWOT Analysis
10.13.6. Key Strategies
10.14. Meril Life Sciences Pvt. Ltd.
10.14.1. Company Overview
10.14.2. Financial Overview
10.14.3. Products Offered
10.14.4. Key Developments
10.14.5. SWOT Analysis
10.14.6. Key Strategies
10.15. MicroPort Scientific Corporation
10.15.1. Company Overview
10.15.2. Financial Overview
10.15.3. Products Offered
10.15.4. Key Developments
10.15.5. SWOT Analysis
10.15.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL POLYMER BIOMATERIALS MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL POLYMER BIOMATERIALS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 7 US: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 8 US: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 9 CANADA: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 10 CANADA: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 3 GERMANY: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 FRANCE: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 6 FRANCE: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 7 ITALY: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 8 ITALY: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 9 SPAIN: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 10 SPAIN: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 11 UK: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 12 UK: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 13 REST OF EUROPE: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 14 REST OF EUROPE: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 15 ASIA-PACIFIC: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 16 ASIA-PACIFIC: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 17 JAPAN: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 18 JAPAN: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 19 CHINA: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 20 CHINA: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 21 INDIA: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 22 INDIA: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 23 AUSTRALIA: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 24 AUSTRALIA: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 25 SOUTH KOREA: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 26 SOUTH KOREA: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 27 REST OF ASIA-PACIFIC: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 28 REST OF ASIA-PACIFIC: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 29 REST OF THE WORLD: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 30 REST OF THE WORLD: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 31 MIDDLE EAST: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 32 MIDDLE EAST: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 33 AFRICA: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 34 AFRICA: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 35 LATIN AMERICA: POLYMER BIOMATERIALS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 36 LATIN AMERICA: POLYMER BIOMATERIALS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL POLYMER BIOMATERIALS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL POLYMER BIOMATERIALS MARKET
FIGURE 4 GLOBAL POLYMER BIOMATERIALS MARKET, SHARE (%), BY PRODUCT, 2023
FIGURE 5 GLOBAL POLYMER BIOMATERIALS MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 6 GLOBAL POLYMER BIOMATERIALS MARKET, SHARE (%), BY REGION, 2023
FIGURE 7 NORTH AMERICA: POLYMER BIOMATERIALS MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 EUROPE: POLYMER BIOMATERIALS MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 ASIA-PACIFIC: POLYMER BIOMATERIALS MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 REST OF THE WORLD: POLYMER BIOMATERIALS MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 GLOBAL POLYMER BIOMATERIALS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 12 STRYKER: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 STRYKER: SWOT ANALYSIS
FIGURE 14 BASF SE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 BASF SE: SWOT ANALYSIS
FIGURE 16 EVONIK INDUSTRIES AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 EVONIK INDUSTRIES AG: SWOT ANALYSIS
FIGURE 18 DSM: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 DSM: SWOT ANALYSIS
FIGURE 20 BEZWADA BIOMEDICAL, LLC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 BEZWADA BIOMEDICAL, LLC.: SWOT ANALYSIS
FIGURE 22 CORBION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 CORBION: SWOT ANALYSIS
FIGURE 24 VICTREX PLC (INVIBIO LTD.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 VICTREX PLC (INVIBIO LTD.): SWOT ANALYSIS
FIGURE 26 INTERNATIONAL POLYMER ENGINEERING: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 INTERNATIONAL POLYMER ENGINEERING: SWOT ANALYSIS
FIGURE 28 COVALON TECHNOLOGIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 COVALON TECHNOLOGIES LTD.: SWOT ANALYSIS
FIGURE 30 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 MEDTRONIC: SWOT ANALYSIS
FIGURE 32 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 ABBOTT: SWOT ANALYSIS
FIGURE 34 ELIXIR MEDICAL: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 ELIXIR MEDICAL: SWOT ANALYSIS
FIGURE 36 REVA MEDICAL, LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 REVA MEDICAL, LLC: SWOT ANALYSIS
FIGURE 38 MERIL LIFE SCIENCES PVT. LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 MERIL LIFE SCIENCES PVT. LTD.: SWOT ANALYSIS
FIGURE 40 MICROPORT SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 MICROPORT SCIENTIFIC CORPORATION: SWOT ANALYSIS
